004310.KS · 현대약품
South Korea · RS rating 70 · As of 2026-10-14
| Price | 7,530.00 KRW |
|---|---|
| 1-day change | -1.3% |
| RS rating (overall / 1M / 3M / 12M) | 70 / 4 / 93 / 91 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 40 / 36 / 46 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | +143.8% |
| Sales growth Q/Q | +19.7% |
| Distance from 52-week high | +47.5% |
| Market cap (USD) | $178.7M |